Routine Use of Gradient-Echo MRI to Screen for Cerebral Amyloid Angiopathy in Elderly Patients
AJR 182:1547-1550, Walker,D.A., et al, 2004

Guillain-Barre Syndrome Seen in Users of Isotretinoin
BMJ 328:1537, Pritchard,J.,et al, 2004

Fish Consumption and Incidence of Stroke
Stroke 35:1538-1542, He,K.,et al, 2004

Normal Intelligence in Children with Prenatal Exposure to Carbamazepine
Neurol 62:28-32,8, Gaily,E.,et al, 2004

Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements
Arch Neurol 61:82-88, Zandi,P.P.,et al, 2004

Clopidogrel-Associated TTP, An Update of Pharmacovigilance Efforts
Stroke 35:533-538, Zakarija,A.,et al, 2004

Antithrombotic Drugs for Carotid Artery Dissection
Stroke 25:613-614, Lyrer,P.&Engelter,S., 2004

Benefit of Clopidogrel Over Aspirin is Amplified in Patients with a History of Ischemic Events
Stroke 35:528-532, Ringleb,P.A.,et al, 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004

Variants and Mimics of Guillain Barre Syndrome
The Neurologist 10:61-74, Levin,K.H., 2004

Prescription of Antithrombotic Therapy in Older Patients Hospitalized for Transient Ischemic Attack and Ischemic Stroke:The GIFA Study
Stroke 35:913-917, Volpato,S.,et al, 2004

Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004

Antiplatelet Therapy for Preventing Stroke and Other Vascular Events After Carotid Endarterectomy
Stroke 35:1227-1228, Engelter,S. &Lyrer,P., 2004

Valproate Therapy and Nonalcoholic Fatty Liver Disease
Ann Neurol 55:729-732, Luef,G.J.,et al, 2004

Hyperhomocysteinemia as an Independent Risk Factor for Silent Brain Infarction
Neurol 61:1595-1599, Kim,N.K.,et al, 2003

10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003

Pernicious Anemia with Neuropsychiatric Dysfunction in a Patient with Sickle Cell Anemia Treated with Folate Supplementation
NEJM 348:2204-2207, Dhar,M.,et al, 2003

Neurotoxicity Following Addition of Intravenous Valproate to Lamotrigine Therapy
Neurol 60:1991-1992, Burneo,J.G.,et al, 2003

Anticoagulants Versus Antiplatelet Agents for Acute Ischemic Stroke
Stroke 34:1571-1572, Berge,E. &Sandercock,P., 2003

Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Arch Neurol 60:940-946,923, Morris,M.C.,et al, 2003

Antiplatelet Therapy in Aneurysmal Subarachnoid Hemorrhage, A Systematic Review
Stroke 34:2285-2289, Mees,S.M.D.,et al, 2003

Antifibrinolytic Therapy for Aneurysmal Subarachnoid Hemorrhage, A Major Update of a Cochrane Review
Stroke 34:2308-2309, Roos,Y.,et al, 2003

Gamma Hydroxybutyrate Intoxication
NEJM 349:1267-1275, Case 30-2003, 2003

Diagnostic Approach in Patients with Symmetric Imaging Lesions of the Deep Gray Nuclei
The Neurologist 9:250-261, Finelli,P.F.&DiMario,Jr,F.J., 2003

Should I Start All My Ischaemic Stroke and TIA Patients on a Statin, an ACE Inhibitor, a Diuretic, and Aspirin Today?
JNNP 74:1461-1464, Sandercock,P.A.G., 2003

Dietary Antioxidants and the Risk of Ischemic Stroke
Neurol 61:1273-1275, Voko,Z.,et al, 2003

Continuation of Medically Necessary Aspirin and Warfarin During Cutaneous Surgery
Mayo Clin Proc 78:1392-1396, Otley,C.C., 2003

Stroke
Lancet 362:1211-1224, Warlow,C.,et al, 2003

Clinicopath Conf., Colchicine Myoneuropathy
NEJM 349:1656-1663, Case 33-2003, 2003

Neurological Aspects of Biological and Chemical Terrorism
Arch Neurol 60:21-25, Martin,C.O., &Adams,H.P., 2003

Antioxidant Vitamin Intake and Risk of Alzheimer Disease
Arch Neurol 60:203-208, Luchsinger,J.A.,et al, 2003

Asymptomatic Microbleeds as a Risk Factor for Aspirin-Associated Intracerebral Hemorrhages
Neurol 60:511-513, Wong,K.S.,et al, 2003

Major Malformations in Offspring of Women with Epilepsy
Neurol 60:575-579, Kaaja,E.,et al, 2003

Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Further Vascular Events After Transient Ischemic Attack or Minor Stroke of Presumed Arterial Origin
Stroke 34:234-235, Algra,A.,et al, 2003

Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003

Platelet Function Under Aspirin, Clopidogrel, and Both After Ischemic Stroke
Stroke 34:849-855, Grau,A.J.,et al, 2003

The Emergency Management of Headaches
The Neurologist 9:93-98, Green,M.W., 2003

Risks and Benefits of Anticoagulant and Antiplatelet Medication Use Before Cataract Surgery
Ophthalmology 110:1784-1788, Katz,J.,et al, 2003

Mutations in the Molybdenum Cofactor Biosynthetic Genes MOCS1, MOCS2, and GEPH
Hum Mutat 21:569-576, Reiss,J. &Johnson,J.L., 2003

Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003

Laughing Headache: A Novel Type of Triggered Headache with Response to Divalproex Sodium
Headache 43:801-803, Levin,M. &Ward,T.N., 2003

A Practical Approach to the Diagnosis and Management of MELAS: Case Report and Review
The Neurologist 8:302-312, Thambisetty,M.,et al, 2002

Glutamic Acid Decarboxylase Autoantibodies and Neurological Disorders
Neurol Sci 23:145-151, Vianello,M.,et al, 2002

Tranexamic Acid in Hereditary Hemorrhagic Telangiectasia
NEJM 346:457, Sabra,C.,et al, 2002

Symptoms of B12 Deficiency Can Occur in Women of Child Bearing Age Supplemented with Folate
Neurol 58:1572-1573, Drazkowski,J.,et al, 2002

Dietary Intake of Folate and Risk of Stroke in US Men and Women
Stroke 33:1183-1189, Bazzano,L.A.,et al, 2002

Prognostic Significance of Uric Acid Serum Concentration in Patients with Acute Ischemic Stroke
Stroke 33:1048-1052, Chamorro,A.,et al, 2002

Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial
Stroke 33:1723-1726, Hankey,G.J., 2002